NT5E and cancer: Different tumor tissues and cancer cell lines express purinergic receptors and CD39/CD73 ectonucleotidases, generating diverse cellular responses that could depend directly on the cell context and the specific set of purinergic signaling components expressed by the tumor and host cells, known by some authors as the “purinome” [12].